Daily Current Affairs / DCGI approves two clinical trials of indigenous Covid vaccine Corbevax
Category : National Published on: September 04 2021
· The Drug Controller General of India- DCGI has approved two clinical trials of indigenous Covid vaccine Corbevax.
· Vaccine maker Biologicals E has received permission for Phase II and III trials on children between the ages of five and eighteen under certain conditions.
· The Department of Biotechnology and its PSU Biotechnology Industry Research Assistance Council – BIRAC have provided support to Biologicals E's COVID-19 Vaccine.
· This support will be provided from the preclinical phase to the third phase of the trial.
Important facts
About the DCGI
v DCGI: Drugs Controller General of India
v Headquarters location: New Delhi